EGFR and squamous cell carcinoma: The findings obtained in this investigation indirectly concur with the observations made with the intravenous application of cetuximab in patients undergoing therapy of metastatic colorectal cancer or advanced squamous cell carcinoma of head and neck with EGFR expression13,14.